New app and MRI tool aim to improve MS care

NCT ID NCT05949580

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests a digital platform that combines an app for patients and a brain-scan analysis tool for doctors. The goal is to see if it helps monitor multiple sclerosis (MS) more easily in everyday care. About 500 people with relapsing-remitting MS will use the app and have their MRI scans analyzed by the platform over two years. Researchers will ask doctors and patients how user-friendly and helpful the platform is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MS Care Platform (icobrain ms and icompanion ms)
What this could lead to
If successful, this platform could give doctors better tools to track MS progression and adjust treatments more quickly.
What could go wrong
This is an early-stage usability study, not a treatment trial. It measures how well doctors and patients like the platform, not whether it improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601, United States

  • Hospital General Universitario Dr. Balmis

    Alicante/alacant, Alicante, 03010, Spain

  • Hospital Universitario de Gran Canaria

    Las Palmas, 35010, Spain

  • Jersey Shore University Medical Centre

    Neptune City, New Jersey, 07753, United States

  • Minneapolis Clinic of Neurology

    Golden Valley, Minnesota, 55422, United States

  • Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim

    Sinsheim, 74889, Germany

  • Universitaetsklinikum Carl Gustav Carus an der TU Dresden

    Dresden, 01307, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.